Sarasota Skin And Cancer Center Inc

CLIA Laboratory Citation Details

3
Total Citations
9
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 10D1018060
Address 2179 S Tamiami Trl Ste 101, Osprey, FL, 34229
City Osprey
State FL
Zip Code34229
Phone(941) 966-0222

Citation History (3 surveys)

Survey - May 25, 2022

Survey Type: Standard

Survey Event ID: L0Z611

Deficiency Tags: D0000 D5209 D3011 D5413

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Sarasota Skin and Cancer Center Inc. on 05/25/22. The laboratory is not in compliance with 42 CFR Part 493, Requirements for Laboratories. The following is a description of the standard level deficiencies: D3011 FACILITIES CFR(s): 493.1101(d) Safety procedures must be established, accessible, and observed to ensure protection from physical, chemical, biochemical, and electrical hazards, and biohazardous materials. This STANDARD is not met as evidenced by: Based on observation and interview with the MOHS Tech, the laboratory failed to dispose of 95% Reagent Alcohol, 100% Reagent Alcohol, Hematoxylin Stain Solution, Eosin Y Stain Solution, and Histo-Clear according to manufacturer's instructions for 2 out of 2 (2020-2022) years reviewed. Findings Included: Observation of reagents in the flammable cabinet on 05/25/2022 at 10:00 a.m. revealed the labels on the 95% Reagent Alcohol, 100% Reagent Alcohol, Hematoxylin Stain Solution, Eosin Y Stain Solution, and Histo-Clear noted "Dispose of contents/container to an approved waste disposal plant." On 05/25/22 at 10:20 a.m., the MOHS Tech stated that the observed reagents were disposed of down the drain of the sink. The MOHS Tech reported she did not know she should follow the manufacturer's instructions. Photographic evidence was obtained. D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- consultant competency. This STANDARD is not met as evidenced by: Based on record review and interview with Laboratory Staff, the laboratory failed to have documentation of competency assessments for three out of three (#B, #C, #D) Testing Personnel for two out of two years reviewed (2020-2022). Findings Included: Review of the CMS 209 signed by the Laboratory Director on 05/23/22 revealed three Testing Personnel (#B, #C, and #D). Review of the laboratory procedure titled "Initial and Annual Laboratory Employee Evaluation" revealed the Medical Director must perform the initial six month and annual competency. Review of Testing Personnel files revealed: Testing Personnel #B performed histopathology slide interpretation and had worked at the facility since the prior recertification survey conducted 2/13/20. Testing Personnel #B had only 1 competency assessment on file, dated 05/2022. Testing Personnel #C performed histopathology grossing and had had worked at the facility since the prior recertification survey conducted 2/13/20. Testing Personnel #C had only 1 competency assessment on file, dated 1/31/20. Testing Personnel #D performed histopathology grossing and had no competency assessments on file. A telephone interview on 05/25/22 at 11:10 AM with Testing Personnel #D confirmed no competency assessments had been performed on her. A telephone interview on 05 /25/22 at 12:10 PM with the Medical Assistant confirmed that Testing Personnel #C and #D did not have competency assessments performed for 2021 and 2022. On 05/25 /22 at 12:30 PM, Testing Personnel #B stated she thought the peer review was the competency assessment. This is a repeat deficiency. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on record review and interview with Testing Personnel #D, the laboratory failed to follow the laboratory's policy for the temperature of the water bath for 432 days out of 432 days of testing from February 14, 2020 to May 25, 2022. Findings Included: Review of the laboratory's policy and procedure titled "Microtomy" revealed "Make sure water bath is at proper temperature which is 36 degrees Celsius to 42 degrees Celsius..." Review of the "Premier Water Bath Temperature and Maintenance log" and the "HT - 075 Water Bath Quality Control & Maintenance Log" revealed the temperature of the water bath had been documented as 44 degrees for 432 days out of 432 days of testing from February 14, 2020 to May 25, 2022 (date of survey). A telephone interview on 5/25/22 at 11:05 am with Testing Personnel #D confirmed the water bath temperatures were out of the range of 36 - 42 degrees Celsius. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 13, 2020

Survey Type: Standard

Survey Event ID: 939511

Deficiency Tags: D5209 D0000

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Sarasota Skin and Cancer Center Inc. on 02/13/2020. The laboratory is not in compliance with 42 CFR Part 493, Requirements for Laboratories. The following is a description of the standard level deficiencies: D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on record review and interview with the Office Manager the laboratory failed to perform competency evaluations on 2 (#C and #D) of 2 Testing Personnel (TP) performing Moderately Complex Testing for 2 out of 2 years (2018-2020) reviewed. Findings Included: Review of the CMS 209 signed and dated by the Laboratory Director on 02/10/2020 revealed that there were 2 TP (#C and #D) who performed Moderately Complex Testing (Potassium hydroxide and Scabies testing). Review of employee competency testing revealed no competencies for TP #C and #D. On 02/13 /2020 at 11:00 AM, the Office Manager confirmed no competency evaluations for TP #C and #D. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 1, 2018

Survey Type: Standard

Survey Event ID: 3KAR11

Deficiency Tags: D5217 D5200 D5805

Summary:

Summary Statement of Deficiencies D5200 GENERAL LABORATORY SYSTEMS CFR(s): 493.1230 Each laboratory that performs nonwaived testing must meet the applicable general laboratory systems requirements in 493.1231 through 493.1236, unless HHS approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing. The laboratory must monitor and evaluate the overall quality of the general laboratory systems and correct identified problems specified in 493.1239 for each specialty and subspecialty of testing performed. This CONDITION is not met as evidenced by: Based on record review and interview with the Medical Assistant, the laboratory failed to evaluate the accuracy of the Scabies and Potassium Hydroxide (KOH) testing at least twice a year for 1 (2016) out of 2 years(2016-2017) for the Scabies testing and 2 (2016 and 2017) out of 2 years for the KOH testing (See D5217). This is a repeat deficiency from the recertification survey conducted on 2/12/2014. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on record review and interview with the Medical Assistant, the laboratory failed to evaluate the accuracy of the Scabies and Potassium Hydroxide (KOH) testing at least twice a year for 1 (2016) out of 2 years(2016-2017) for the Scabies testing and 2 (2016 and 2017) out of 2 years for the KOH testing. This is a repeat deficiency from the recertification survey conducted 02/12/14. Findings Included: Review of peer Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- reviews for Scabies found them done 03/10/17 and 03/19/17. There was no documentation of reviews performed for 2016. Review of peer reviews for KOH found them done 01/25/17 and 11/22/16. No other documentation of reviews were provided. During an interview on 02/01/18 at 2:00 PM the Medical Assistant revealed that no other peer reviews were available for review. Review of the recertification survey conducted on 02/12/14, revealed that not performing Scabies peer review was a repeat deficiency. The

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access